← Scroll for more →
Financial Statements — MASK
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q2 2025 | Q4 2024 |
|---|---|---|---|
| Cash & Equivalents | 0.04 | 0.07 | 0.07 |
| Accounts Receivable | 4.40 | 2.68 | -- |
| Total Current Assets | 9.75 | 3.19 | -- |
| Property, Plant & Equipment | -- | 0.01 | -- |
| Total Non-current Assets* | 3.61 | 2.18 | -- |
| Total Assets | 13.36 | 5.37 | -- |
| Accounts Payable | 2.54 | 0.80 | -- |
| Total Current Liabilities | 3.24 | 1.49 | -- |
| Total Non-current Liabilities* | 1.57 | 0.09 | -- |
| Total Liabilities | 4.80 | 1.57 | -- |
| Retained Earnings | 3.13 | 3.88 | -- |
| Total Stockholder Equity | 8.56 | 3.79 | 3.79 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD)| Metric | Q2 2025 |
|---|---|
| Total Revenue | 3.13 |
| Cost of Revenue | 1.53 |
| Gross Profit | 1.59 |
| Research & Development | 0.15 |
| Selling, General & Admin | 0.20 |
| Total Operating Expenses | 0.33 |
| Operating Income | 1.27 |
| Pretax Income | 1.27 |
| Tax Provision | 0.20 |
| Net Income | 1.07 |
← Scroll for more columns →
Cash Flow Statement
(in thousands USD)| Metric | Q2 2025 |
|---|---|
| Operating Cash Flow | 389.45 |
| Financing Cash Flow | (355.61) |
← Scroll for more columns →